CLINICAL_TRIALS
research
· 2016-08-11
Clinical Trial Update: From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers [NA]
Summary
This clinical trial update discusses deregulation of the cholesterol-epoxide pathway in breast cancer and explores potential new therapeutic perspectives.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institut Claudius Regaud | Conditions: Breast Cancer | NA | Status: UNKNOWN